BioCentury
ARTICLE | Company News

Molecular Targeting Technologies, Medical College of Wisconsin deal

August 6, 2012 7:00 AM UTC

The college granted Molecular Targeting an exclusive license to a patent covering the synthesis and characterization of 99mTc-Duramycin for the non-invasive imaging of dead and dying cells. Molecular ...